Akanda Corp. (AKAN) vs Sonoma Pharmaceuticals, Inc. (SNOA)
- Akanda Corp. AKAN 1.20 −8.40%
- Sonoma Pharmaceuticals, Inc. SNOA 1.13 −1.74%
Akanda Corp. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sonoma Pharmaceuticals, Inc. is the larger, with a market value of $5.5M against $3.5M — 1.6× the size. Across the 10 metrics below, Akanda Corp. leads on 8 and Sonoma Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | AKAN | SNOA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | — | 38.91% | 53.94% |
| Operating margin | — | (6.41%) | 0.00% |
| Net margin | — | (10.33%) | 0.00% |
| Free cash flow margin | 0.00% | (12.11%) | 0.00% |
| Return on equity | 0.00% | (42.52%) | (0.40%) |
| Return on assets | 0.00% | (13.85%) | (3.32%) |
| Return on invested capital | 0.00% | (69.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack